D., Moffatt, K., Council on Sports Medicine and Fitness, LaBella, C
Among the rare ocular side effects of GLP-1RAs is non-arteritic anterior ischemic optic neuropathy (NAION), which can cause permanent loss of vision, states the report, Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice. The report was first presented at the 2025 Optometry's Meeting | 5th World Congress of Optometry and is meant to provide critical guidance to doctors of optometry treating patients on GLP-1RAs
Lilly, for instance, recently claimed that a newer incretin drug in its pipeline, brenipatide, has optimal properties for neuroscience indications. Yet, in that wide research area, the company is initially testing brenipatide as a treatment for alcohol use disorder and opioid use disorder
doi: 10.1002/hep4.1088 76 NetoJOVda SilvaCAde MatosRSSouzaFRNogueiraEFHallakJet al
Truworth Healthcare , Plot no- 167, JP